SQSTM1 and hepatocellular carcinoma: Similarly, CEP treatment caused accumulation of LC3B-II and SQSTM1 in SMMC-7721 (a human hepatocellular carcinoma cell line), K562 (a human leukemia cell line), and A549 (a human lung cancer cell line) cells (Fig. 1f).